Bruce C. Trapnell

机构：Cincinnati Children's Hospital Medical Center · ORCID：0000-0003-2817-6254

发表论文 321 篇 · 总被引 21257 次 · h-index 81

代表论文

• Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial (2022 · Annals of the Rheumatic Diseases · 被引 127)
• Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial (2021 · The Lancet Rheumatology · 被引 69)
• Inhaled recombinant GM-CSF reduces the need for whole lung lavage and improves gas exchange in autoimmune pulmonary alveolar proteinosis patients (2023 · European Respiratory Journal · 被引 51)
• Identification of Distinct Inflammatory Programs and Biomarkers in Systemic Juvenile Idiopathic Arthritis and Related Lung Disease by Serum Proteome Analysis (2022 · Arthritis & Rheumatology · 被引 50)
• Phase 3 Trial of Inhaled Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis (2025 · New England Journal of Medicine · 被引 26)
• Alpha-1 antitrypsin limits neutrophil extracellular trap disruption of airway epithelial barrier function (2023 · Frontiers in Immunology · 被引 22)